Outlook Therapeutics, Inc. — DEF 14A Filings
12 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Outlook Therapeutics, Inc. (OTLK), sorted by most recent first. Each row links to the full filing on EdgarLookup. Outlook Therapeutics, Inc. has filed 12 DEF 14A documents with the SEC since 2015. To view all SEC filings by Outlook Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
PRE 14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001140361-26-002406 | Jan 26, 2026 | Mar 10, 2026 |
| DEF 14A | FORM DEF 14A | 0001104659-25-010946 | Feb 10, 2025 | Mar 11, 2025 |
| DEF 14A | DEF 14A | 0001104659-24-074966 | Jun 26, 2024 | Aug 12, 2024 |
| DEF 14A | DEF 14A | 0001104659-24-011916 | Feb 8, 2024 | Mar 7, 2024 |
| DEF 14A | DEF 14A | 0001104659-23-022226 | Feb 15, 2023 | Mar 29, 2023 |
| DEF 14A | DEF 14A | 0001104659-22-008303 | Jan 27, 2022 | Mar 23, 2022 |
| DEF 14A | DEF 14A | 0001104659-21-026016 | Feb 22, 2021 | Mar 24, 2021 |
| DEF 14A | DEF 14A | 0001104659-20-096526 | Aug 18, 2020 | Sep 17, 2020 |
| DEF 14A | DEF 14A | 0001104659-20-021988 | Feb 14, 2020 | Mar 19, 2020 |
| DEF 14A | DEF 14A | 0001144204-19-037252 | Aug 1, 2019 | Sep 12, 2019 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001144204-18-045240 | Aug 17, 2018 | Sep 21, 2018 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001571049-17-008053 | Sep 29, 2017 | Oct 26, 2017 |